A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression

NCT02189057 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Depression
Mood Disorder
Bipolar

Interventions

OTHER: AssureRx GeneSight genotyping results
OTHER: Treatment as usual

Sponsor

Mayo Clinic